274 related articles for article (PubMed ID: 24526059)
1. Thrombolysis in the 3- to 4.5-hour window: what do ECASSkeptics want?
Selim MH; Molina CA
Stroke; 2014 Mar; 45(3):916-7. PubMed ID: 24526059
[No Abstract] [Full Text] [Related]
2. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
Wechsler LR
Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
[No Abstract] [Full Text] [Related]
3. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
Schellinger PD; Köhrmann M
Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
[No Abstract] [Full Text] [Related]
4. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
Moonis M
Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
[No Abstract] [Full Text] [Related]
5. Thrombolysis, community hospitals, and primary stroke center.
Jeng JS
Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
[No Abstract] [Full Text] [Related]
6. IV and IA thrombolytic stroke strategies are complementary.
Donnan GA; Davis SM
Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
[No Abstract] [Full Text] [Related]
7. Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
Lindley RI
Stroke; 2009 Jul; 40(7):2613-4. PubMed ID: 19443793
[No Abstract] [Full Text] [Related]
8. Intravenous recombinant tissue-type plasminogen activator in the extended time window and the US Food and Drug Administration: confused about the time.
Wechsler LR; Jovin TG
Stroke; 2012 Sep; 43(9):2517-9. PubMed ID: 22910892
[No Abstract] [Full Text] [Related]
9. IV tissue plasminogen activator for stroke in the community: what we know and don't know 10 years after FDA approval.
Furlan AJ
Stroke; 2006 Feb; 37(2):281. PubMed ID: 16397163
[No Abstract] [Full Text] [Related]
10. [Thrombolysis in stroke--results of the ECASS study (European Cooperative Acute Stroke Study)].
Nervenarzt; 1995 Aug; 66(8 Suppl):1-8. PubMed ID: 9131091
[No Abstract] [Full Text] [Related]
11. Yes, intravenous thrombolysis should be administered in pregnancy when other clinical and imaging factors are favorable.
Demchuk AM
Stroke; 2013 Mar; 44(3):864-5. PubMed ID: 23391770
[No Abstract] [Full Text] [Related]
12. Estimated weight is not a reliable measure for dosing tissue plasminogen activator for thrombolysis in acute ischaemic stroke.
Gill D; Halsey L; Kalkat H; Patel S; Kar A
Int J Stroke; 2016 Feb; 11(2):NP25-6. PubMed ID: 26783320
[No Abstract] [Full Text] [Related]
13. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
[No Abstract] [Full Text] [Related]
14. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
Sharma VK; Teoh HL; Chan BP
J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
[No Abstract] [Full Text] [Related]
15. Intravenous thrombolysis.
Nguyen TH; Truong AT; Ngo MB; Bui CT; Dinh QV; Doan TC; Nguyen LT; Phan TC; Phan MV; Nguyen TV; Le TV
Int J Stroke; 2010 Dec; 5(6):516. PubMed ID: 21050414
[No Abstract] [Full Text] [Related]
16. Current acute stroke trials and their potential impact on the therapeutic time window.
Schellinger PD; Köhrmann M
Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
[TBL] [Abstract][Full Text] [Related]
17. [Thrombolytic therapy: formation and current practice of intravenous thrombolysis in acute ischemic stroke].
Iavorskaia VA; Flomin IuV; D'olog NV; Grebeniuk AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():13-27. PubMed ID: 16447549
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in older adults.
Dirks M; Koudstaal PJ; Dippel DW; Niessen LW; van Wijngaarden JD; Franke CL; van Oostenbrugge RJ
J Am Geriatr Soc; 2011 Nov; 59(11):2169-71. PubMed ID: 22098036
[No Abstract] [Full Text] [Related]
19. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
[TBL] [Abstract][Full Text] [Related]
20. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
